Nonviral Methods for siRNA Delivery

被引：195

作者：

Gao, Kun ^{[2
]}

Huang, Leaf ^{[1
]}

机构：

[1] Univ N Carolina, Div Mol Pharmaceut, Sch Pharm, Chapel Hill, NC 27599 USA

[2] Xi An Jiao Tong Univ, Key Lab Biomed Informat Engn, Minist Educ, Sch Life Sci & Technol, Xian 710049, Peoples R China

来源：

MOLECULAR PHARMACEUTICS | 2009年 / 6卷 / 03期

关键词：

RNA interference; small interfering RNA; delivery; nanoparticles; SMALL INTERFERING RNA; INHIBITS TUMOR-GROWTH; IN-VIVO DELIVERY; SYSTEMIC DELIVERY; GENE-EXPRESSION; DRUG-DELIVERY; PAMAM DENDRIMERS; SYNTHETIC SIRNAS; VITRO; LIPOSOMES;

D O I：

10.1021/mp800134q

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

RNA interference (RNAi) as a mechanism to selectively degrade mRNA (mRNA) expression has emerged as a potential novel approach for drug target validation and the study of functional genomics. Small interfering RNAs (siRNA) therapeutics has developed rapidly and already there are clinical trials ongoing or planned. Although other challenges remain, delivery strategies for siRNA become the main hurdle that must be resolved prior to the full-scale clinical development of siRNA therapeutics. This review provides an overview of the current delivery strategies for synthetic siRNA, focusing on the targeted, self-assembled nanoparticles which show potential to become a useful and efficient tool in cancer therapy.

引用

页码：651 / 658

页数：8

共 95 条

[1]

AAGAARD L, 2000, ADV DRUG DELIVERY RE, V59, P75

[2] Delivery systems for the direct application of siRNAs to induce RNA interference (RNAi) in vivo [J].

Aigner, Achim .

JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2006,

[3] RNAi-induced gene silencing by local electroporation in targeting brain region [J].

Akaneya, Y ;

Jiang, B ;

Tsumoto, T .

JOURNAL OF NEUROPHYSIOLOGY, 2005, 93 (01) :594-602

[4] Nonviral delivery of synthetic siRNAs in vivo [J].

Akhtar, Saghir ;

Benter, Ibrahim F. .

JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (12) :3623-3632

[5] Toxicogenomics of non-viral drug delivery systems for RNAi: Potential impact on siRNA-mediated gene silencing activity and specificity [J].

Akhtar, Saghir ;

Benter, Ibrahim .

ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (2-3) :164-182

[6] Specific β1-adrenergic receptor silencing with small interfering RNA lowers high blood pressure and improves cardiac function in myocardial ischemia [J].

Arnold, Anne-Sophie ;

Tang, Yao Liang ;

Qian, Keping ;

Shen, Leping ;

Valencia, Valery ;

Phillips, Michael Ian ;

Zhang, Yuan Clare .

JOURNAL OF HYPERTENSION, 2007, 25 (01) :197-205

[7] Anisamide-targeted stealth liposomes: A potent carrier for targeting doxorubicin to human prostate cancer cells [J].

Banerjee, R ;

Tyagi, P ;

Li, S ;

Huang, L .

INTERNATIONAL JOURNAL OF CANCER, 2004, 112 (04) :693-700

[8] Inhibition of respiratory viruses by nasally administered siRNA [J].

Bitko, V ;

Musiyenko, A ;

Shulyayeva, O ;

Barik, S .

NATURE MEDICINE, 2005, 11 (01) :50-55

[9] RNAi therapeutics: a potential new class of pharmaceutical drugs [J].

Bumcrot, David ;

Manoharan, Muthiah ;

Koteliansky, Victor ;

Sah, Dinah W. Y. .

NATURE CHEMICAL BIOLOGY, 2006, 2 (12) :711-719

[10] Novel cationic cardiolipin analogue-based liposome for efficient DNA and small interfering RNA delivery in vitro and in vivo [J].

Chien, PY ;

Wang, JK ;

Carbonaro, D ;

Lei, S ;

Miller, B ;

Sheikh, S ;

Ali, SM ;

Ahmad, MU ;

Ahmad, I .

CANCER GENE THERAPY, 2005, 12 (03) :321-328

← 1 2 3 4 5 6 7 8 9 10 →